← FDA Drug Approvals (Drugs@FDA)
ROCURONIUM BROMIDE
ANDA · Abbreviated New Drug Application (Generic) · Sponsor: CAPLIN · Approved 2023-03-02
Drug application
- FDA Application #
ANDA216234- Application type
- Abbreviated New Drug Application (Generic)
- Brand name
- ROCURONIUM BROMIDE
- Generic name
- ROCURONIUM BROMIDE
- Active ingredients
- ROCURONIUM BROMIDE
- Dosage form
- INJECTABLE
- Route
- INJECTION
- Marketing status
- Prescription
- Sponsor
- CAPLIN
- Manufacturer
- BE Pharmaceuticals Inc.
- First approval
- 2023-03-02
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown